Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
29 hedge funds and large institutions have $5.21M invested in Zosano Pharma Corporation in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 7 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
0% more funds holding
Funds holding: 29 → 29 (0)
16.82% less ownership
Funds ownership: 33.86% → 17.04% (-17%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less capital invested
Capital invested by funds: $10.5M → $5.21M (-$5.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Telemetry Investments
New York
|
+$1.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$392K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$195K |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$57.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$44.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$152K |
| 2 |
JP Morgan Chase
New York
|
-$93K |
| 3 |
IC
IEQ Capital
Foster City,
California
|
-$79K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$57K |
| 5 |
Jane Street
New York
|
-$20K |
ZSAN Hedge Fund Activity: Q1 2020 in Review
29 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2020, worth a combined $5.21M — down 50% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ZSAN positions and 7 closed out — a net gain of 2 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Telemetry Investments, adding an estimated $1.67M. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $152K sold.
- 29 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $5.21M of Zosano Pharma Corporation stock for Q1 2020, down 50% quarter-over-quarter.
- 9 funds opened new Zosano Pharma Corporation positions in Q1 2020 and 7 closed out, a net change of +2 holders.
- The largest Zosano Pharma Corporation buyer in Q1 2020 was Telemetry Investments, an estimated $1.67M added.
- The largest Zosano Pharma Corporation seller in Q1 2020 was FNY Investment Advisers, an estimated $152K sold.
Based on aggregated 13F filings for Q1 2020.